Pauline Murphy

SVP and Chief Information and Process Officer

📍 Rocky Hill, Connecticut, United States🔄 Updated September 2026💼 7 investments📅 20 years investing🗓 Last invested Jan 2018
Angel investor🌍 United States
7
Total investments
1
Early stage
3
Mid stage
1
Late stage
20y
Years active

Portfolio

6 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Jan 2018
Portfolio of medical device technologies and virtual care services in the food allergy space
Board Member
Sep 2017
LambdaVision is leveraging space to develop a protein-based artificial retina to restore meaningful vision for the millions of patients blinded by retinal degenerative diseases. View our Community Guidelines: https://bit.ly/LambdaVisionCGs
late stageBiotechnology
Board Member
May 2017
FITSCRIPT™ is a digital health company revolutionizing the treatment of diabetes with GlucoseZone, the first and only digital therapeutic designed to address the exercise component of diabetes self-management. Through the power of data, GlucoseZone is able to offer individualized, biometrically driven content, guidance, and support to enable people to utilize fitness and nutrition to reduce, reverse, and control their diabetes.
Board Observer
Jul 2016
Cadenza Innovation, Inc., based in Connecticut, was founded in 2012 by Dr. Christina Lampe-Onnerud, founder and former CEO of Boston-Power, and one of the pre-eminent battery experts in the world. Christina has once again assembled a world-class team, many of whom had key leadership roles at Boston-Power, with a ground-breaking battery pack architecture and global Tier 1 partners. Cadenza Innovation (originally named CLOTEAM) is poised to become a world leader in battery architecture, performance and safety, with a mission to solve big problems through innovation in technology. Our companys mission is to deploy our innovation, intellectual property, field-proven operational and mass production expertise, along with our key technology partners to build Cadenza Innovation into a global technology leader in energy density, lowest cost, and safety. Cadenza Innovation is licensing its technology to allow immediate access to its highly simplified design for large lithium-ion energy storage systems. Cadenza’s unique cell design combines the best properties from wound jelly rolls and large prismatic cells and allows for game-changing high energy density at low cost for EV, PHEV and grid markets. What’s in a Name? The word “cadenza” comes from the world of music and refers to a moment in a piece when a musician within the ensemble is allowed some freedom of expression and artistry in the work. We recognize that every member of the Cadenza Innovation ensemble has a unique perspective and we want to hear it. Our goal is to combine creativity with deep industry knowledge to drive innovative solutions into global energy markets. We are delighted to include many high-powered “guest soloists” and “conductors” into our expanding band. Cadenza Innovation is not just a name – it’s an expression of the culture underpinning our company.
Board Observer
Jul 2016
Cadenza Innovation, Inc., based in Connecticut, was founded in 2012 by Dr. Christina Lampe-Onnerud, founder and former CEO of Boston-Power, and one of the pre-eminent battery experts in the world. Christina has once again assembled a world-class team, many of whom had key leadership roles at Boston-Power, with a ground-breaking battery pack architecture and global Tier 1 partners. Cadenza Innovation (originally named CLOTEAM) is poised to become a world leader in battery architecture, performance and safety, with a mission to solve big problems through innovation in technology. Our companys mission is to deploy our innovation, intellectual property, field-proven operational and mass production expertise, along with our key technology partners to build Cadenza Innovation into a global technology leader in energy density, lowest cost, and safety. Cadenza Innovation is licensing its technology to allow immediate access to its highly simplified design for large lithium-ion energy storage systems. Cadenza’s unique cell design combines the best properties from wound jelly rolls and large prismatic cells and allows for game-changing high energy density at low cost for EV, PHEV and grid markets. What’s in a Name? The word “cadenza” comes from the world of music and refers to a moment in a piece when a musician within the ensemble is allowed some freedom of expression and artistry in the work. We recognize that every member of the Cadenza Innovation ensemble has a unique perspective and we want to hear it. Our goal is to combine creativity with deep industry knowledge to drive innovative solutions into global energy markets. We are delighted to include many high-powered “guest soloists” and “conductors” into our expanding band. Cadenza Innovation is not just a name – it’s an expression of the culture underpinning our company.
Board Member
May 2016
Bioarray Genetics is a biotech company located in New Haven, Connecticut. We are committed to transforming cancer treatment decisions and outcomes using gene profiling to provide clinically actionable results to clinicians and patients. Our BA100 Triple Negative Breast Cancer Stratification Test, addresses a significant area of unmet medical need. Until now, no stratification test existed for Triple Negative Breast Cancer (TNBC) Patients like there are for HER2+ and ER+ Breast Cancers. The lack of a stratification test that can identify patients according to their likelihood of treatment response meant that every TNBC Patient would get the same treatment option. It took eight years to understand which TNBC Patients would not achieve a complete response to the standard-of-care chemotherapy. We found part of the answer in what are called Housekeeping Genes – the genes responsible for maintaining the minute-by-minute clockwork in breast tissue cells. Surprisingly, when the Triple Negative Cancer Cells prohibit Housekeeping Genes from doing their jobs, the tumor’s response to the standard-of-care chemotherapy changes. Combining this discovery with others, Bioarray Genetics created the BA100 Triple Negative Breast Cancer Stratification Test. Using the BA100 test, we not only know that approximately 67% of Triple Negative Breast Cancer Patients will not achieve a complete response to the standard-of-care chemotherapy, but we can identify who they are prior to treatment. BA100 is now available to select Oncologists and Patients throughout the United States. For more information, please visit http://bioarray.us/.
Experience · 10 entries
All (10)
Investments (7)
Board (7)
2018
Board Member
Jan 2018
Portfolio of medical device technologies and virtual care services in the food allergy space
2017
Board Member
Sep 2017
LambdaVision is leveraging space to develop a protein-based artificial retina to restore meaningful vision for the millions of patients blinded by retinal degenerative diseases. View our Community Guidelines: https://bit.ly/LambdaVisionCGs
late stageBiotechnology
Board Member
May 2017
FITSCRIPT™ is a digital health company revolutionizing the treatment of diabetes with GlucoseZone, the first and only digital therapeutic designed to address the exercise component of diabetes self-management. Through the power of data, GlucoseZone is able to offer individualized, biometrically driven content, guidance, and support to enable people to utilize fitness and nutrition to reduce, reverse, and control their diabetes.
2016
Board Observer
Jul 2016
Cadenza Innovation, Inc., based in Connecticut, was founded in 2012 by Dr. Christina Lampe-Onnerud, founder and former CEO of Boston-Power, and one of the pre-eminent battery experts in the world. Christina has once again assembled a world-class team, many of whom had key leadership roles at Boston-Power, with a ground-breaking battery pack architecture and global Tier 1 partners. Cadenza Innovation (originally named CLOTEAM) is poised to become a world leader in battery architecture, performance and safety, with a mission to solve big problems through innovation in technology. Our companys mission is to deploy our innovation, intellectual property, field-proven operational and mass production expertise, along with our key technology partners to build Cadenza Innovation into a global technology leader in energy density, lowest cost, and safety. Cadenza Innovation is licensing its technology to allow immediate access to its highly simplified design for large lithium-ion energy storage systems. Cadenza’s unique cell design combines the best properties from wound jelly rolls and large prismatic cells and allows for game-changing high energy density at low cost for EV, PHEV and grid markets. What’s in a Name? The word “cadenza” comes from the world of music and refers to a moment in a piece when a musician within the ensemble is allowed some freedom of expression and artistry in the work. We recognize that every member of the Cadenza Innovation ensemble has a unique perspective and we want to hear it. Our goal is to combine creativity with deep industry knowledge to drive innovative solutions into global energy markets. We are delighted to include many high-powered “guest soloists” and “conductors” into our expanding band. Cadenza Innovation is not just a name – it’s an expression of the culture underpinning our company.
Board Observer
Jul 2016
Cadenza Innovation, Inc., based in Connecticut, was founded in 2012 by Dr. Christina Lampe-Onnerud, founder and former CEO of Boston-Power, and one of the pre-eminent battery experts in the world. Christina has once again assembled a world-class team, many of whom had key leadership roles at Boston-Power, with a ground-breaking battery pack architecture and global Tier 1 partners. Cadenza Innovation (originally named CLOTEAM) is poised to become a world leader in battery architecture, performance and safety, with a mission to solve big problems through innovation in technology. Our companys mission is to deploy our innovation, intellectual property, field-proven operational and mass production expertise, along with our key technology partners to build Cadenza Innovation into a global technology leader in energy density, lowest cost, and safety. Cadenza Innovation is licensing its technology to allow immediate access to its highly simplified design for large lithium-ion energy storage systems. Cadenza’s unique cell design combines the best properties from wound jelly rolls and large prismatic cells and allows for game-changing high energy density at low cost for EV, PHEV and grid markets. What’s in a Name? The word “cadenza” comes from the world of music and refers to a moment in a piece when a musician within the ensemble is allowed some freedom of expression and artistry in the work. We recognize that every member of the Cadenza Innovation ensemble has a unique perspective and we want to hear it. Our goal is to combine creativity with deep industry knowledge to drive innovative solutions into global energy markets. We are delighted to include many high-powered “guest soloists” and “conductors” into our expanding band. Cadenza Innovation is not just a name – it’s an expression of the culture underpinning our company.
Show all 10 entries ↓
Investment activity
2006–2018 · 7 investments
20061201632017220181
Recent (last 2 years)Earlier